8-K: ETST Launches Telehealth Platform, Boosts Vertical Integration

Earth Science Tech, Inc. announced the launch of MyOnlineConsultation.com, completing its vertically integrated telehealth and pharmacy ecosystem and achieving cash-flow positive status during its beta phase.

Summary

• Earth Science Tech, Inc. (ETST) officially launched MyOnlineConsultation.com through its MOCTeledoc, LLC subsidiary.
• This launch finalizes ETST's fully vertically integrated telehealth and pharmacy ecosystem.
• MOCTeledoc achieved cash-flow positive status during its beta phase, validating its lean business model.
• The new platform will synchronize a prescriber network directly with ETST's compounding pharmacies (RxCompound and Mister Meds) and other external pharmacies.
• All vertically integrated services will be marketed nationwide under the "Peaks" brand to drive cross-divisional revenue.
• Management projects MOCTeledoc to become a significant revenue stream, complementing the existing compounding and direct-to-consumer divisions which generated $25.9 million in revenue for the nine months ended December 31, 2025.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a highly positive development, given the immediate cash-flow positive status of the new division and its strategic importance in completing the company's vertical integration in the growing telehealth sector.

Positives

• The new MOCTeledoc division achieved cash-flow positive status during its beta phase, indicating a validated and lean business model.
• The launch completes a fully vertically integrated telehealth and pharmacy ecosystem, enhancing operational synergies.
• Management anticipates the new division will be immediately accretive to the company's bottom line.
• The platform creates a new revenue stream and a powerful funnel for in-house pharmacies.
• The company's existing compounding and direct-to-consumer divisions generated $25.9 million in revenue for the nine months ended December 31, 2025.

Risks

• Actual results may differ materially from forward-looking statements due to various risks and uncertainties.
• Risks include the markets for the company's products and services.
• Costs of goods and services and other expenses could impact financial performance.
• Government regulations may affect operations.
• Litigations could arise.
• General business conditions may fluctuate.

Future Outlook

Management projects MOCTeledoc will become a significant revenue stream and be immediately accretive to the company's bottom line as it rolls out nationwide. The company anticipates continued growth by leveraging its vertically integrated healthcare ecosystem and the "Peaks" brand.

Management Comments

• "Achieving cash-flow-positive results during our beta phase confirms the power of our product, and we anticipate this division will be immediately accretive to our bottom line as we roll it out nationwide."
• "By offering our custom platform and dedicated prescriber network as a turnkey service, we have not only created a new revenue stream but also established a powerful funnel for our in-house pharmacies."

Industry Context

StockSavvy.ai notes that the launch of MyOnlineConsultation.com positions ETST to capitalize on the growing demand for telehealth services, a trend accelerated by recent global events. The vertical integration strategy, combining telemedicine with compounding pharmacies, mirrors efforts by larger healthcare players to control the entire patient journey, potentially enhancing efficiency and patient retention in a competitive digital health landscape.

Comparison to Industry Standards

• The achievement of cash-flow positive status during a beta phase for a new telehealth platform is a strong indicator, often surpassing the initial ramp-up periods seen in many digital health startups that require significant upfront investment before profitability.
• ETST's strategy of integrating a prescriber network with compounding pharmacies (like RxCompound and Mister Meds) creates a closed-loop system, similar to models adopted by vertically integrated pharmacy benefit managers (PBMs) or large healthcare systems, aiming for greater control over prescription fulfillment and patient care pathways.
• The projected "significant revenue stream" from MOCTeledoc, alongside existing divisions' $25.9 million revenue for nine months, suggests a potentially robust growth trajectory, though specific market share or growth rate comparisons to industry leaders like Teladoc Health or Amwell are not provided in the filing.

Stakeholder Impact

• Shareholders: Potential for increased revenue and profitability from the new division, leading to enhanced shareholder value.
• Customers (Patients): Access to a more integrated and streamlined telehealth and pharmacy service under the "Peaks" brand.
• Employees: Potential for growth and expansion within the MOCTeledoc and related divisions.
• Pharmacies (internal and external): Direct routing and integration with a prescriber network could increase prescription volume.

Next Steps

• Roll out the MOCTeledoc division nationwide.
• Market the vertically integrated suite of services under the "Peaks" brand.

Key Dates

Recommendation

The launch of a new, immediately cash-flow positive telehealth division that completes a strategic vertical integration is a significant positive catalyst. This move is expected to be accretive to the bottom line and create new revenue streams, positioning the company favorably in the high-growth digital health market. The existing revenue base of $25.9 million from other divisions further strengthens the company's foundation.

Keywords

Earth Science Tech, ETST, MyOnlineConsultation, MOCTeledoc, Telehealth, Telemedicine, Pharmacy, Compounding Pharmacy, Healthcare Ecosystem, Vertical Integration, Digital Health, OTC